Assessing respiratory mechanics and muscle function is critical for both clinical practice and
research purposes. Several methodological developments over the past two decades have …

COPD is associated with a progressive loss of muscle mass and function. However, there is
an unmet need to define and standardise methods to estimate the prevalence of sarcopenia …

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a major transcription factor involved in
redox homeostasis and in the response induced by oxidative injury. Nrf2 is present in an …

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death
worldwide. Current COPD diagnosis (ie, spirometry) could be unreliable because the test …

The proportion of obese or overweight patients in COPD patients is increasing. Although
BMI, WC and other easy to measure indicators have been proven to be related to the risk of …

Mesenchymal cells are an essential cell type because of their role in tissue support, their
multilineage differentiation capacities and their potential clinical applications. They play a …

Sarcopenia and osteoporosis are common musculoskeletal comorbidities of chronic
obstructive pulmonary disease (COPD) that seriously affect the quality of life and prognosis …

Patients with chronic obstructive pulmonary disease (COPD) present with an advanced form
of age-related muscle loss or sarcopenia. Among multiple pathomechanisms of sarcopenia …

Background Sarcopenia is characterized by the loss of skeletal muscle mass and strength
and is associated with poor prognosis in patients with chronic obstructive pulmonary …

Simple Summary As we grow older, our muscles become smaller and weaker, a condition
called sarcopenia. Several lung diseases can further worsen sarcopenia. Among them …